Trials / Completed
CompletedNCT01698294
Biomarkers in Post-Menopausal Women Receiving Flaxseed
A Pilot Study of the Flaxseed Effects on Hormones and Lignans: Role of Race, Genes, and Gut Microbiome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.
Detailed description
PRIMARY OBJECTIVES: I. To determine associations between the composition of the gut bacterial communities and baseline levels of the mammalian lignans and steroid hormones. II. To determine how variation in gut microbial community composition and in steroid hormone and xenobiotic metabolizing genes affects the metabolism of mammalian lignans and steroid hormones after exposure to a lignan-rich food (flaxseed). III. To determine how these associations differ by race (i.e., African American and European American women). OUTLINE: Participants are randomized to 1 of 2 treatment groups. GROUP I: Participants receive flaxseed orally (PO) daily for 6 weeks. After a usual diet "washout" period of 8 weeks, patients crossover to Group II. GROUP II: Participants maintain a usual diet for 6 weeks. After a usual diet "washout" period of 8 weeks, patients crossover to Group I. After completion of study treatment, participants are followed up for 30 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Clinical Observation | Participants maintain usual diet and undergo clinical observation |
| DIETARY_SUPPLEMENT | Flaxseed | Given PO |
| OTHER | Laboratory Biomarker Analysis | Correlative studies |
| OTHER | Questionnaire Administration | Ancillary studies |
Timeline
- Start date
- 2012-12-14
- Primary completion
- 2017-06-08
- Completion
- 2017-06-08
- First posted
- 2012-10-02
- Last updated
- 2022-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01698294. Inclusion in this directory is not an endorsement.